Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest:The ALPS Study (Amiodarone, Lidocaine, or Placebo)

Peter J. Kudenchuk, Brian G. Leroux, Mohamud Daya, Thomas Rea, Christian Vaillancourt, Laurie J. Morrison, Clifton W. Callaway, James Christenson, Joseph P. Ornato, James V. Dunford, Lynn Wittwer, Myron L. Weisfeldt, Tom P. Aufderheide, Gary M. Vilke, Ahamed H. Idris, Ian G. Stiell, M. Riccardo Colella, Tami Kayea, Debra Egan, Patrice Desvigne-NickensPamela Gray, Randal Gray, Ron Straight, Paul Dorian

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest:The ALPS Study (Amiodarone, Lidocaine, or Placebo)'. Together they form a unique fingerprint.

Medicine & Life Sciences